Expression change of nuclear receptor corepressor (NCoR) in androgen independence prostate cancer and its clinical significance

Your Location：

Home >

Browse articles >

Expression change of nuclear receptor corepressor (NCoR) in androgen independence prostate cancer and its clinical significance

Updated：2026-03-12

- Expression change of nuclear receptor corepressor (NCoR) in androgen independence prostate cancer and its clinical significance
- Expression change of nuclear receptor corepressor (NCoR) in androgen independence prostate cancer and its clinical significance
- 解放军医学杂志（英文版） 2005年0卷第4期页码：241-244
- Affiliations：
  
  1. Department of Urology
  2. Research Institute of Field Surgery
  3. Daping Hospital
  4. Third Military Medical University
  5. ,China
  6. Department of Pathology
- Author bio：
- Funds：
- DOI：
  中图分类号： R737.25
- 纸质出版：2005
- Accepted：
Scan QR Code
Expression change of nuclear receptor corepressor (NCoR) in androgen independence prostate cancer and its clinical significance[J]. 解放军医学杂志（英文版）, 2005,0(4):241-244.

Expression change of nuclear receptor corepressor (NCoR) in androgen independence prostate cancer and its clinical significance[J]. Military Medical Research2005, 0(4): 241-244.
Expression change of nuclear receptor corepressor (NCoR) in androgen independence prostate cancer and its clinical significance[J]. 解放军医学杂志（英文版）, 2005,0(4):241-244. DOI：

Expression change of nuclear receptor corepressor (NCoR) in androgen independence prostate cancer and its clinical significance[J]. Military Medical Research2005, 0(4): 241-244. DOI：

摘要

Abstract

关键词

Keywords

references

浏览量

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Performance of GPT-4 for automated prostate biopsy decision-making based on mpMRI: a multi-center evidence study

Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021

ADP-dependent glucokinase: the ancient, archaeal key to prostate cancer

The implications of single-cell RNA-seq analysis in prostate cancer: unraveling tumor heterogeneity, therapeutic implications and pathways towards personalized therapy